Skip to main content
Log in

Preparation and Evaluation of Sustained-Release Matrix Tablets Based on Metoprolol and an Acrylic Carrier Using Injection Moulding

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Sustained-release matrix tablets based on Eudragit RL and RS were manufactured by injection moulding. The influence of process temperature; matrix composition; drug load, plasticizer level; and salt form of metoprolol: tartrate (MPT), fumarate (MPF) and succinate (MPS) on ease of processing and drug release were evaluated. Formulations composed of 70/30% Eudragit RL/MPT showed the fastest drug release, substituting part of Eudragit RL by RS resulted in slower drug release, all following first-order release kinetics. Drug load only affected drug release of matrices composed of Eudragit RS: a higher MPT concentration yielded faster release rates. Adding triethyl citrate enhanced the processability, but was detrimental to long-term stability. The process temperature and plasticizer level had no effect on drug release, whereas metoprolol salt form significantly influenced release properties. The moulded tablets had a low porosity and a smooth surface morphology. A plasticizing effect of MPT, MPS and MPF on Eudragit RS and Eudragit RL was observed via DSC and DMA. Solubility parameter assessment, thermal analysis and X-ray diffraction demonstrated the formation of a solid solution immediately after production, in which H-bonds were formed between metoprolol and Eudragit as evidenced by near-infrared spectroscopy. However, high drug loadings of MPS and MPF showed a tendency to recrystallise during storage. The in vivo performance of injection-moulded tablets was strongly dependent upon drug loading.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

REFERENCES

  1. Quinten T, De Beer T, Remon JP, Vervaet C. Overview of injection molding as a manufacturing technique for pharmaceutical application. In: Kauffer PH, editor. Injection molding: process, design and application. New York: Nova; 2011. p. 1–42.

    Google Scholar 

  2. Cheng L, Guo S, Wu W. Characterization and in vitro release of praziquantel from poly(ε-caprolactone) implants. Int J Pharm. 2009;377:112–9.

    Article  PubMed  CAS  Google Scholar 

  3. Zema L, Loreti G, Melocchi A, Maroni A, Gazzania A. Injection molding and its application to drug delivery. J Control Release. 2012;159:324–31.

    Article  PubMed  CAS  Google Scholar 

  4. Quinten T, De Beer T, Onofre FO, Mendez-Montealvo G, Wang YJ, Remon JP, et al. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation. J Pharm Sci. 2011;100:2858–70.

    Article  PubMed  CAS  Google Scholar 

  5. Quinten T, De Beer T, Vervaet C, Remon JP. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets. Eur J Pharm Biopharm. 2009;71:145–54.

    Article  PubMed  CAS  Google Scholar 

  6. Quinten T, Gonissen Y, Cnudde V, Masschaele B, Van Hoorebeke L, Remon JP, et al. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose. Eur J Pharm Sci. 2009;37:207–16.

    Article  PubMed  CAS  Google Scholar 

  7. Quinten T, De Beer T, Almeida A, Vlassenbroeck J, Van Hoorebeke L, Remon JP, et al. Development and evaluation of injection moulded sustained release tablets containing ethylcellulose and polyethylene oxide. Drug Dev Ind Pharm. 2011;37:149–59.

    Article  PubMed  CAS  Google Scholar 

  8. Andrews GP, Abudiak OA, Jones DS. Physicochemical characterisation of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. J Pharm Sci. 2010;99:1322–35.

    Article  PubMed  CAS  Google Scholar 

  9. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47–60.

    Article  PubMed  CAS  Google Scholar 

  10. Schilling SU, Bruce CD, Shah NH, Malick AW, McGinity JW. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets. Int J Pharm. 2008;361:158–68.

    Article  PubMed  CAS  Google Scholar 

  11. Zhu YC, Shah NH, Malick AW, Infeld MH, McGinity JW. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate. Int J Pharm. 2002;241:301–10.

    Article  PubMed  CAS  Google Scholar 

  12. Gordon S, Taylor JS. Ideal copolymers and the second-order transitions of synthetic rubbers. I Non-crystalline copolymers. J Appl Chem. 1952;2:493–500.

    Article  CAS  Google Scholar 

  13. Suhma R, Boyer RF. General relation involving the glass transition temperature and coefficient of expansion of polymers. J Chem Phys. 1962;37:1003–7.

    Article  Google Scholar 

  14. De Brabander C, Van Den Mooter G, Vervaet C, Remon JP. Characterization of ibuprofen as a nontradional plasticizer of ethyl cellulose. J Control Release. 2003;91:1678–85.

    Google Scholar 

  15. Breitzkreus J. Prediction of intestinal drug absorption properties by three-dimensional solubility parameters. Pharm Res. 1998;15:1370–5.

    Article  Google Scholar 

  16. Blomqvist I, Westergren G, Sandberg A, Jonsson UE, Lundborg P. Pharmacokinetics and pharmacodynamics of controlled release metoprolol: a comparison with atenolol. Eur J Clin Pharmacol. 1988;33:S19–24.

    Article  PubMed  CAS  Google Scholar 

  17. Fang J, Semple HA, Song J. Determination of metoprolol, and its four metabolites in dog plasma. J Chromatogr B. 2004;809:9–14.

    Article  CAS  Google Scholar 

  18. Lin SY, Yu HL. Microscopic Fourier transform infrared/differential scanning calorimetry systems used to study the different thermal behaviours of polymethacrylate copolymers of Eudragit RS, RL, E30D or E. J Appl Polym Sci. 2000;78:829–35.

    Article  CAS  Google Scholar 

  19. Hancock BC, York P, Raymond CR. The use of solubility parameters in pharmaceutical dosage form design. Int J Pharm. 1997;148:1–21.

    Article  CAS  Google Scholar 

  20. Greenhalgh D, Williams AC, Timmins P, York P. Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci. 1999;88:1182–90.

    Article  PubMed  CAS  Google Scholar 

  21. Chokshi RJ, Sandhu HK, Iyer RM, Shah NH, Malick AW, Zia H. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution. J Pharm Sci. 2005;94:2463–74.

    Article  PubMed  CAS  Google Scholar 

  22. Forster A, Hempenstall J, Tucker I, Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm. 2001;226:147–61.

    Article  PubMed  CAS  Google Scholar 

  23. Forster A, Hempenstall J, Rades T. Characterisation of glass solutions of poorly soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J Pharm Pharmacol. 2000;53:303–15.

    Article  Google Scholar 

  24. Chokski RJ, Shah NH, Sandhu HK, Malick AW, Zia H. Stabilisation of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. J Pharm Sci. 2007;97:2286–98.

    Article  Google Scholar 

  25. Glaessl B, Siepmann F, Tucker I, Siepmann J, Rades T. Characterisation of quaternary polymethacryalate films containing tartaric acid, metoprolol free base or metoprolol tartrate. Eur J Pharm Biopharm. 2009;73:366–72.

    Article  PubMed  CAS  Google Scholar 

  26. Weyer L, Lo S-C. Handbook of vibrotional spectroscopy: spectra—structure correlations in the near-infrared. New York: Wiley; 2006.

    Google Scholar 

  27. Carli F, Capone G, Colombo I, Magarotto L, Motta A. Surface and transport properties of acrylic polymers influence drug release from porous matrices. Int J Pharm. 1984;21:317–29.

    Article  CAS  Google Scholar 

  28. Glaessl B, Siepmann F, Tucker I, Rades T, Siepmann J. Deeper insight into the drug release machanism in Eudragit RL-based delivery systems. Int J Pharm. 2010;389:139–46.

    Article  PubMed  CAS  Google Scholar 

  29. Ragnarsson G, Sandberg A, Johansson MO, Lindstedt B, SJögren J. In vitro release characteristics of a membrane-coated pellet formulation—influence of drug solubility and particle size. Int J Pharm. 1992;79:223–32.

    Article  CAS  Google Scholar 

  30. Ravishankar H, Patil P, Samel A, Petereit H-U, Lizio R. Controlled release by permeability alteration of cationic ammonio methacrylate copolymers using ionic interactions. Drug Dev Ind Pharm. 2006;32:709–18.

    Article  PubMed  CAS  Google Scholar 

  31. Wagner KG, McGinity JW. Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films. J Control Release. 2002;82:385–97.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Vervaet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quinten, T., Andrews, G.P., De Beer, T. et al. Preparation and Evaluation of Sustained-Release Matrix Tablets Based on Metoprolol and an Acrylic Carrier Using Injection Moulding. AAPS PharmSciTech 13, 1197–1211 (2012). https://doi.org/10.1208/s12249-012-9848-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-012-9848-6

KEY WORDS

Navigation